Dual enzyme biocatalyst
A range of enantiomerically pure chiral amines have been prepared by a collaboration of scientists in the UK and the US.
Nicholas Turner and Matthew Truppo from the University of Manchester and a co-worker from Codexis Incorporated, California, have synthesised a range of enantiomerically pure (R)- and (S)-configured chiral amines.
Enantiomerically pure chiral amines are important as they have applications in a number of different areas including building blocks for pharmaceuticals, resolving agents and ligands for asymmetric synthesis. In order to minimize the cost of production it is important to devise efficient catalytic methods for their preparation, particularly on a large scale.
Turner and his team have developed a novel biocatalytic system, involving the use of two enzymes (transaminase and amino acid oxidase), for the kinetic resolution of a range of racemic amines. Both (R)- and (S)-configured chiral amines can be prepared using this approach with high enantioselectivity (e.e. >99%). Turner explains that ‘the key to our method is to use a catalytic (as low as 0.05 mol%) quantity of the amine acceptor pyruvate, which is converted to alanine during the transamination of a ketone substrate. The addition of L- or D-amino acid oxidase results in the efficient conversion of the alanine back to pyruvate.’
‘The process is fast, generally applicable, and should be amenable to rapid scale-up by those in industry wishing to apply this method to specific chiral amines of interest,’ says Turner.
Original article: Matthew D. Truppo et. al.; "Efficient kinetic resolution of racemic amines using a transaminase in combination with an amino acid oxidase"; Chem. Commun. 2009
Most read news
Organizations
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Analytik Jena Wins Major Order in Poland
Schizophrenia manifests itself in the brain structure - The symptoms of schizophrenia vary greatly from person to person
The race is on for new lithium ion batteries - Battery consortium headed by BASF receives € 21 million sponsorship from German Ministry of Education and Research
Antibiotic resistance testing no longer impeded by time - Researchers have developed a novel method for antibiotic resistance testing that might transform microbial screening in clinical and research labs
A new way to stimulate cellular recycling process
Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement - Offer price increased
New insights into the function of a risk factor for Alzheimer’s disease - Researchers decipher the structure-function relationship of the multifunctional protein clusterin for the first time
Rigaku opens Rigaku Technology Center Taiwan - Advancing regional growth through engineering and collaboration in Taiwan and beyond
Multiplexed Morse signals from cells
Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease
Closing in on the elusive rotational-vibrational CH5+ spectra